BRIEF-Incyte Corp says EVP Richard Levy to retire
April 18, 2016 at 07:47 AM EDT
* Richard Levy, EVP and chief drug development officer of co, notified company of intention to retire effective April 30 Source text for Eikon: Further company coverage: )
